JP2005060406A5 - - Google Patents

Download PDF

Info

Publication number
JP2005060406A5
JP2005060406A5 JP2004293637A JP2004293637A JP2005060406A5 JP 2005060406 A5 JP2005060406 A5 JP 2005060406A5 JP 2004293637 A JP2004293637 A JP 2004293637A JP 2004293637 A JP2004293637 A JP 2004293637A JP 2005060406 A5 JP2005060406 A5 JP 2005060406A5
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2004293637A
Other languages
Japanese (ja)
Other versions
JP2005060406A (ja
Filing date
Publication date
Application filed filed Critical
Publication of JP2005060406A publication Critical patent/JP2005060406A/ja
Publication of JP2005060406A5 publication Critical patent/JP2005060406A5/ja
Pending legal-status Critical Current

Links

JP2004293637A 1993-04-27 2004-10-06 ワクチン用免疫原性lhrhペプチド構築体および合成普遍免疫刺激器 Pending JP2005060406A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US5716693A 1993-04-27 1993-04-27
US22927594A 1994-04-14 1994-04-14

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP52461494A Division JP3795914B2 (ja) 1993-04-27 1994-04-28 ワクチン用免疫原性lhrhペプチド構築体および合成普遍免疫刺激器

Publications (2)

Publication Number Publication Date
JP2005060406A JP2005060406A (ja) 2005-03-10
JP2005060406A5 true JP2005060406A5 (cg-RX-API-DMAC7.html) 2005-09-08

Family

ID=26736147

Family Applications (2)

Application Number Title Priority Date Filing Date
JP52461494A Expired - Lifetime JP3795914B2 (ja) 1993-04-27 1994-04-28 ワクチン用免疫原性lhrhペプチド構築体および合成普遍免疫刺激器
JP2004293637A Pending JP2005060406A (ja) 1993-04-27 2004-10-06 ワクチン用免疫原性lhrhペプチド構築体および合成普遍免疫刺激器

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP52461494A Expired - Lifetime JP3795914B2 (ja) 1993-04-27 1994-04-28 ワクチン用免疫原性lhrhペプチド構築体および合成普遍免疫刺激器

Country Status (11)

Country Link
EP (1) EP0708656B1 (cg-RX-API-DMAC7.html)
JP (2) JP3795914B2 (cg-RX-API-DMAC7.html)
AT (1) ATE221387T1 (cg-RX-API-DMAC7.html)
AU (1) AU687805B2 (cg-RX-API-DMAC7.html)
CA (1) CA2161445C (cg-RX-API-DMAC7.html)
DE (1) DE69431114T2 (cg-RX-API-DMAC7.html)
DK (1) DK0708656T3 (cg-RX-API-DMAC7.html)
ES (1) ES2180576T3 (cg-RX-API-DMAC7.html)
FI (1) FI955101A7 (cg-RX-API-DMAC7.html)
NO (1) NO316121B1 (cg-RX-API-DMAC7.html)
WO (1) WO1994025060A1 (cg-RX-API-DMAC7.html)

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6607727B1 (en) 1991-08-26 2003-08-19 The Scripps Research Institute Peptides for inducing cytotoxic T lymphocyte responses to hepatitus B virus
US6235288B1 (en) 1992-08-26 2001-05-22 The Scripps Research Institute Peptides for inducing cytotoxic T lymphocyte responses to hepatitis B virus
CN1118573A (zh) * 1993-02-26 1996-03-13 斯克瑞普斯研究所 诱导细胞毒t淋巴细胞应答乙型肝炎病毒的肽类
US5688506A (en) 1994-01-27 1997-11-18 Aphton Corp. Immunogens against gonadotropin releasing hormone
WO1995026365A1 (en) * 1994-03-28 1995-10-05 United Biomedical, Inc. Synthetic peptide based immunogens for the treatment of allergy
US6410022B1 (en) 1995-05-01 2002-06-25 Avant Immunotherapeutics, Inc. Modulation of cholesteryl ester transfer protein (CETP) activity
JP3910635B2 (ja) 1995-06-06 2007-04-25 アバント イミュノーセラピューティクス,インコーポレイテッド Hdlコレステロールレベルを増大する方法
US5843462A (en) 1995-11-30 1998-12-01 Regents Of The University Of Minnesota Diphtheria toxin epitopes
TR199801722T2 (xx) 1996-03-01 1998-12-21 Novartis Ag Peptit imm�nojenler.
WO1997040161A1 (en) * 1996-04-19 1997-10-30 Henry M. Jackson Foundation For The Advancement Of Military Medecine Histidine-tagged intimin and methods of using intimin to stimulate an immune response and as an antigen carrier with targeting capability
JP2000510332A (ja) 1996-04-19 2000-08-15 ヘンリー エム.ジャクソン ファンデーション フォー ザ アドバンスメント オブ ミリタリー メディシン インチミンを単独で、または1以上の他の抗原との融合タンパク質として発現する宿主生物の投与による、免疫応答を刺激する方法
US6284533B1 (en) 1996-05-01 2001-09-04 Avant Immunotherapeutics, Inc. Plasmid-based vaccine for treating atherosclerosis
US6846808B1 (en) 1996-05-01 2005-01-25 Avant Immunotherapeutics, Inc. Plasmid-based vaccine for treating atherosclerosis
US6309646B1 (en) 1996-05-09 2001-10-30 The Henry M. Jackson Foundation For The Advancement Of Military Medicine Protein-polysaccharide conjugate vaccines and other immunological reagents prepared using homobifunctional and heterobifunctional vinylsulfones, and processes for preparing the conjugates
DE69739233D1 (de) * 1996-06-25 2009-03-12 Pepscan Systems Bv Ein durch labile bindung an einen träger gebundenes antigen enthaltender impstoff
EP0996717B1 (en) * 1997-08-05 2005-12-07 Vlaams Interuniversitair Instituut voor Biotechnologie vzw. Immunoprotective influenza antigen and its use in vaccination
EP1037663A2 (en) 1997-12-16 2000-09-27 Regents Of The University Of Minnesota Methods to treat undesirable immune responses
US6107021A (en) * 1998-06-20 2000-08-22 United Biomedical, Inc. Synthetic peptide vaccines for foot-and-mouth disease
US6025468A (en) * 1998-06-20 2000-02-15 United Biomedical, Inc. Artificial T helper cell epitopes as immune stimulators for synthetic peptide immunogens including immunogenic LHRH peptides
TWI227241B (en) 1998-06-20 2005-02-01 United Biomedical Inc IgE-CH3 domain antigen peptide, peptide conjugate containing the same, and pharmaceutical composition for treating allergies containing the peptide conjugate
US6090388A (en) * 1998-06-20 2000-07-18 United Biomedical Inc. Peptide composition for prevention and treatment of HIV infection and immune disorders
WO2000032626A1 (en) * 1998-11-25 2000-06-08 Regents Of The University Of Minnesota Methods of using epitope peptides of human pathogens
UA81216C2 (en) * 1999-06-01 2007-12-25 Prevention and treatment of amyloid disease
US6783761B2 (en) 2000-05-05 2004-08-31 Aphton Corporation Chimeric peptide immunogens
US6780969B2 (en) * 2000-12-22 2004-08-24 United Biomedical, Inc. Synthetic peptide composition as immunogens for prevention of urinary tract infection
US6906169B2 (en) * 2001-05-25 2005-06-14 United Biomedical, Inc. Immunogenic peptide composition comprising measles virus Fprotein Thelper cell epitope (MUFThl-16) and N-terminus of β-amyloid peptide
US8088388B2 (en) * 2002-02-14 2012-01-03 United Biomedical, Inc. Stabilized synthetic immunogen delivery system
KR100994748B1 (ko) * 2002-04-19 2010-11-17 더 가버닝 카운실 오브 더 유니버시티 오브 토론토 알쯔하이머병의 치료를 위한 면역학적 방법 및 조성물
US8709998B2 (en) 2003-04-22 2014-04-29 Ipsen Pharma S.A.S. Peptide vectors
WO2006026834A1 (en) * 2004-09-10 2006-03-16 The Council Of The Queensland Institute Of Medical Research (Qimr) Truncated lhrh formulations
US7964200B2 (en) 2005-05-18 2011-06-21 Children's Hospital & Research Center At Oakland Methods and compositions for immunizing against Chlamydia infection
EP1890725A2 (en) * 2005-06-01 2008-02-27 Pfizer Products Inc. Vaccine compositions and methods for the treatment of urinary incontinence
US20100286029A1 (en) * 2007-09-11 2010-11-11 Dorian Bevec Use of a peptide as a therapeutic agent
JP4535174B2 (ja) 2008-07-11 2010-09-01 トヨタ自動車株式会社 車両の制御装置および制御方法
HUE051277T2 (hu) 2012-11-16 2021-03-01 United Biomedical Inc Szintetikus peptiden alapuló sürgõsségi vakcina ragadós száj- és körömfájás (FMD) ellen
US20170216418A1 (en) * 2014-07-25 2017-08-03 United Biomedical, Inc. Immunogenic lhrh composition and use thereof in pigs
SG11201908998XA (en) * 2017-03-30 2019-10-30 Progastrine Et Cancers S A R L Compositions and methods for detecting and treating prostate cancer using progastrin binding molecule
MX2021007446A (es) * 2018-12-19 2021-09-08 United Biomedical Inc Epítopos artificiales promiscuos de linfocitos t colaboradores como estimuladores inmunes para inmunógenos peptídicos sintéticos.
TW202144387A (zh) * 2020-02-11 2021-12-01 美商聯合生物醫學公司 針對胰島澱粉樣多肽(iapp)的胜肽免疫原及其預防和治療與聚集iapp相關疾病的製劑

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4613586A (en) * 1984-04-19 1986-09-23 Board Of Trustees Of The Leland Stanford Junior University Gastrin releasing peptide-like peptides
US4608251A (en) * 1984-11-09 1986-08-26 Pitman-Moore, Inc. LHRH analogues useful in stimulating anti-LHRH antibodies and vaccines containing such analogues
EP0301850A3 (en) * 1987-07-31 1990-10-31 Syntex (U.S.A.) Inc. Lhrh antagonist analogs and 19-nor-progestational steroids for therapy
GB8812214D0 (en) * 1988-05-24 1988-06-29 Hoffmann La Roche Use of peptide from circumsporozoite protein of p falciparum as universally recognized t-cell epitope
US5171835A (en) * 1988-10-21 1992-12-15 The Administrators Of The Tulane Educational Fund LHRH antagonists
GB8913737D0 (en) * 1989-06-15 1989-08-02 Univ Birmingham A novel anti-allergy treatment
GB8924438D0 (en) * 1989-10-31 1989-12-20 Hoffmann La Roche Vaccine composition
IT1237764B (it) * 1989-11-10 1993-06-17 Eniricerche Spa Peptidi sintetici utili come carriers universali per la preparazione di coniugati immunogenici e loro impiego per lo sviluppo di vaccini sintetici.
WO1992005192A1 (en) * 1990-09-18 1992-04-02 Biotech Australia Pty. Limited T-cell epitopes
WO1992020370A1 (en) * 1991-05-13 1992-11-26 Regents Of The University Of California Liposomal polysaccharide vaccines
DE69231621T2 (de) * 1991-08-26 2001-05-31 Epimmune, Inc. Hepatitis-B-Virus-Epitope mit HLA-reduzierte CTL-Respons

Similar Documents

Publication Publication Date Title
BE2024C508I2 (cg-RX-API-DMAC7.html)
BE2022C549I2 (cg-RX-API-DMAC7.html)
BE2021C001I2 (cg-RX-API-DMAC7.html)
BE2020C517I2 (cg-RX-API-DMAC7.html)
BE2019C540I2 (cg-RX-API-DMAC7.html)
BE2019C523I2 (cg-RX-API-DMAC7.html)
BE2019C548I2 (cg-RX-API-DMAC7.html)
BE2019C506I2 (cg-RX-API-DMAC7.html)
BE2020C525I2 (cg-RX-API-DMAC7.html)
BE2017C027I2 (cg-RX-API-DMAC7.html)
BE2017C023I2 (cg-RX-API-DMAC7.html)
BE2017C002I2 (cg-RX-API-DMAC7.html)
BE2016C014I2 (cg-RX-API-DMAC7.html)
BE2016C020I2 (cg-RX-API-DMAC7.html)
BE2015C041I2 (cg-RX-API-DMAC7.html)
BE2015C038I2 (cg-RX-API-DMAC7.html)
BE2015C014I2 (cg-RX-API-DMAC7.html)
BE2014C071I2 (cg-RX-API-DMAC7.html)
BE2015C015I2 (cg-RX-API-DMAC7.html)
BE2014C064I2 (cg-RX-API-DMAC7.html)
BE2014C010I2 (cg-RX-API-DMAC7.html)
BE2013C071I2 (cg-RX-API-DMAC7.html)
BE2013C021I2 (cg-RX-API-DMAC7.html)
BE2015C066I2 (cg-RX-API-DMAC7.html)
BE2019C535I2 (cg-RX-API-DMAC7.html)